Cogent Biosciences, Inc. (COGT)
36.96
+1.34
(+3.75%)
USD |
NASDAQ |
Apr 08, 13:13
Cogent Biosciences Cash from Investing (TTM) : -399.53M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Syndax Pharmaceuticals, Inc. | 290.04M |
| Vera Therapeutics, Inc. | 194.29M |
| Terns Pharmaceuticals, Inc. | -298.04M |
| Nuvalent, Inc. | -124.08M |
| Insmed, Inc. | -64.58M |